Fas ligand and immune evasion
- 1 December 1996
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 2 (12) , 1306-1307
- https://doi.org/10.1038/nm1296-1306
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?Nature Medicine, 1996
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996
- The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.The Journal of Experimental Medicine, 1996
- Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in MiceScience, 1996
- Fas ligand in human serumNature Medicine, 1996
- Phosphorus distribution in perichromatin granules and surrounding nucleoplasm as visualized by electron spectroscopic imagingBiology of the Cell, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- The Fas Death FactorScience, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995